Open AccessTumor lysis syndrome in multiple myeloma treated with bortezomib
Author(s) -
K Manoj Dhanraj,
Biswajit Dubashi
Publication year - 2014
Publication title -
journal of pharmacology and pharmacotherapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.301
H-Index - 34
eISSN - 0976-5018
pISSN - 0976-500X
DOI - 10.4103/0976-500x.130091
Subject(s) - bortezomib , tumor lysis syndrome , multiple myeloma , lysis , medicine , cancer research , oncology , immunology , chemotherapy
A 65 year old male diagnosed as multiple myeloma was started on bortezomib developed tumor lysis syndrome. Bortezomib induced tumor lysis is rare and suitable precautions should be considered in these patients.